UNC School of Medicine researchers and colleagues created a germ-free mouse model to evaluate the role of the microbiome in the infection, replication, and pathogenesis of HIV and Epstein-Barr virus, the virus that can cause mononucleosis and other serious diseases.
Read More
Research shows that in addition to HIV’s ability to lay dormant in the blood/lymphoid system, the virus may also lay dormant in the central nervous system, delineating another challenge in creating a cure.
Read More
The long fight to end HIV/AIDS has seen real progress spurred by innovative research, prevention, treatment and education. But our nation’s ambitious goal of ending the HIV epidemic by 2030 is nevertheless in peril. Here are ways to step up the fight.
Read More
An experimental HIV vaccine has been found to induce broadly neutralizing antibody precursors among a small group of volunteers in a Phase 1 study. The findings suggest that a two-dose regimen of the vaccine, given eight weeks apart, can elicit immune responses against the human immunodeficiency virus.
Read More
An immune response that likely evolved to help fight infections appears to be the mechanism that drives human immunodeficiency virus (HIV) into a latent state, lurking in cells only to erupt anew, researchers at Duke Health report.
Read More
Researchers at Duke have published new work in a scientific journal, showing that a potential HIV vaccine component proves effective in primate study.
Read More
Duke will receive a $27 million federal grant over five years to build structural models of the virus that causes AIDS to guide development of new vaccines.
Read More
Drug giant GlaxoSmithKline earned two victories in the ongoing battle to treat AIDS, one involving a patent settlement and the other securing FDA approval for a long-term HIV treatment from GSK-owned ViiV Healthcare.
Read More
The US Food and Drug Administration has approved the first injectable medication for pre-exposure prophylaxis (PrEP) to lower the risk of getting HIV through sex, it announced Monday. And the drug has roots in North Carolina,
Read More
